Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Statistics

Total Valuation

TPE:6838 has a market cap or net worth of TWD 3.90 billion. The enterprise value is 2.49 billion.

Market Cap	3.90B
Enterprise Value	2.49B

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

TPE:6838 has 150.98 million shares outstanding. The number of shares has increased by 7.90% in one year.

Current Share Class	150.98M
Shares Outstanding	150.98M
Shares Change (YoY)	+7.90%
Shares Change (QoQ)	+2.54%
Owned by Insiders (%)	0.95%
Owned by Institutions (%)	9.04%
Float	85.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	411.03
PB Ratio	2.68
P/TBV Ratio	3.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.78
EV / Sales	262.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.55

Financial Position

The company has a current ratio of 9.11, with a Debt / Equity ratio of 0.02.

Current Ratio	9.11
Quick Ratio	8.74
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.26
Interest Coverage	-351.78

Financial Efficiency

Return on equity (ROE) is -5.56% and return on invested capital (ROIC) is -6.97%.

Return on Equity (ROE)	-5.56%
Return on Assets (ROA)	-5.10%
Return on Invested Capital (ROIC)	-6.97%
Return on Capital Employed (ROCE)	-8.96%
Weighted Average Cost of Capital (WACC)	9.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	10
Asset Turnover	0.00
Inventory Turnover	3.14

Taxes

Income Tax	-431,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.34% in the last 52 weeks. The beta is 0.97, so TPE:6838's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	-19.34%
50-Day Moving Average	27.59
200-Day Moving Average	29.97
Relative Strength Index (RSI)	42.29
Average Volume (20 Days)	216,906

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6838 had revenue of TWD 9.50 million and -83.57 million in losses. Loss per share was -0.55.

Revenue	9.50M
Gross Profit	-1.60M
Operating Income	-170.61M
Pretax Income	-84.00M
Net Income	-83.57M
EBITDA	-121.05M
EBIT	-170.61M
Loss Per Share	-0.55

Balance Sheet

The company has 1.44 billion in cash and 26.99 million in debt, with a net cash position of 1.41 billion or 9.37 per share.

Cash & Cash Equivalents	1.44B
Total Debt	26.99M
Net Cash	1.41B
Net Cash Per Share	9.37
Equity (Book Value)	1.46B
Book Value Per Share	9.41
Working Capital	1.35B

Cash Flow

In the last 12 months, operating cash flow was -95.64 million and capital expenditures -10.01 million, giving a free cash flow of -105.65 million.

Operating Cash Flow	-95.64M
Capital Expenditures	-10.01M
Depreciation & Amortization	49.56M
Net Borrowing	-6.13M
Free Cash Flow	-105.65M
FCF Per Share	-0.70

Margins

Gross Margin	-16.83%
Operating Margin	-1,796.85%
Pretax Margin	-884.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6838 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.90%
Shareholder Yield	-7.90%
Earnings Yield	-2.14%
FCF Yield	-2.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:6838 has an Altman Z-Score of 3.52 and a Piotroski F-Score of 1.

Altman Z-Score	3.52
Piotroski F-Score	1